# Glyscend, Inc. — Form D

Glyscend, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-21. The offering totals $20.9M, of which $4.8M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2020-02-21
- Form: D
- Accession: 0001804326-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20.9M
- Amount sold: $4.8M
- Remaining: $16.1M
- Minimum investment: $1
- Investors: 10
- Date of first sale: 2020-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361166

## Issuer

- Name: Glyscend, Inc.
- CIK: 0001804326
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1812 ASHLAND AVE #110, BALTIMORE, MD, 21205
- Phone: 443-961-2147

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Casey Cunningham | Director | Milwaukee, WI |
| Dennis McWilliams | Director | Austin, TX |
| Ashish Nimgaonkar | Director | Baltimore, MD |
| LEIGHTON READ | Director | Sunnyvale, CA |
| Bob Soh | Director | Baltimore, MD |
| Ashish Nimgaonkar | Executive Officer | Baltimore, MD |

## More

- [CIK 1804326 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1804326&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001804326-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.